Encephalomyeloradiculitis after COVID-19 infection.
Yoji HoshinaTakashi TakeuchiPublished in: BMJ case reports (2023)
A woman in her 20s presented with ascending weakness and paraesthesia along with flu-like symptoms. Neurological examination revealed right facial numbness along V2 distribution and flaccidity in her lower extremities, with a motor power of 0/5 throughout. The T4 sensory level and bilaterally positive Babinski sign were noted. Brain MRI revealed multiple bilateral T2/fluid attenuated inversion recovery hyperintense lesions with central enhancement involving the right trigeminal nerve. Full spine MRI demonstrated long-segment thoracic cord demyelination extending from T1 to T11 and nerve root enhancement. An extensive workup for infectious and autoimmune aetiologies was conducted, which revealed a positive COVID-19 result. The patient was diagnosed with encephalomyeloradiculitis secondary to COVID-19 infection. Encephalomyeloradiculitis is a rare neurological condition associated with various underlying conditions. Understanding the causes and differentiating these conditions is essential for appropriate treatment.
Keyphrases
- contrast enhanced
- single cell
- case report
- magnetic resonance imaging
- coronavirus disease
- sars cov
- diffusion weighted imaging
- cerebral ischemia
- computed tomography
- magnetic resonance
- peripheral nerve
- soft tissue
- spinal cord
- resting state
- white matter
- neuropathic pain
- pulmonary artery
- functional connectivity
- coronary artery
- subarachnoid hemorrhage
- brain injury
- replacement therapy
- combination therapy
- pulmonary hypertension
- sleep quality
- drug induced
- pulmonary arterial hypertension